Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 5/20 | 0.72 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.72 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.72 |
| ▸ | SLC18A2 | Q05940 | 3/20 | 0.56 |
| ▸ | LMNA | P02545 | 2/20 | 0.56 |
| ▸ | TSHR | P16473 | 1/20 | 0.56 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.56 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.56 |
| ▸ | HTR2A | P28223 | 1/20 | 0.56 |
| ▸ | HRH1 | P35367 | 1/20 | 0.56 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.56 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30136172 | 1.00 | CYP2D6 (0.72) | CYP2D6CYP1A2HIF1ASLC18A2LMNA | |
| SCHEMBL23415178 | 1.00 | CYP2D6 (0.72) | CYP2D6CYP1A2HIF1ASLC18A2LMNA | |
| SCHEMBL11447464 | 0.95 | CYP2D6 (0.74) | CYP2D6CYP1A2HIF1ASLC18A2LMNA | |
| SCHEMBL21483299 | 0.86 | CYP1A2 (0.51) | CYP2D6CYP1A2HIF1ACHRNB2CHRNA7 | |
| SCHEMBL5948954 | 0.85 | CYP2D6 (0.52) | CYP2D6CYP1A2HIF1ASLC18A2LMNA | |
| SCHEMBL5949491 | 0.85 | CYP2D6 (0.52) | CYP2D6CYP1A2HIF1ASLC18A2LMNA | |
| SCHEMBL5948941 | 0.85 | CYP2D6 (0.52) | CYP2D6CYP1A2HIF1ASLC18A2LMNA | |
| SCHEMBL5949017 | 0.85 | CYP2D6 (0.52) | CYP2D6CYP1A2HIF1ASLC18A2LMNA | |
| SCHEMBL5949021 | 0.85 | CYP2D6 (0.52) | CYP2D6CYP1A2HIF1ASLC18A2LMNA | |
| SCHEMBL5948950 | 0.85 | CYP2D6 (0.52) | CYP2D6CYP1A2HIF1ASLC18A2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2370177-B1 | NOVEL COSMETIC COMPOSITIONS HAVING HAIR GROWTH INHIBITING EFFECT | HENKEL AG & CO KGAA (DE) | 2017-11-15 | — | — | EP | claimed |
| EP-4731602-A1 | NEW CLASS OF LIPIDS FOR DELIVERING ACTIVE INGREDIENTS INTO CELLS | OZ Biosciences (FR) | 2026-04-29 | — | — | EP | disclosed |
| US-12539298-B2 | Lobinaline N-oxides as positive allosteric modulators of the dopamine transporter with potential value in the treatment of substance abuse disorders | UNIV KENTUCKY RES FOUND (US) | 2026-02-03 | — | — | US | disclosed |
| WO-2025080590-A1 | CO-CRYSTALLIZATION OF ACTIVES WITH SACCHARIDE-BASED MOLECULAR FRAMEWORKS | SCIENTIFIC HORIZONS CONSULTING LLC (US) | 2025-04-17 | — | — | WO | disclosed |
| CN-113811532-B | Pesticidally active heterocyclic derivatives with sulfur containing substituents | 先正达农作物保护股份公司 | 2025-04-11 | — | — | CN | disclosed |
| WO-2024261311-A1 | NEW CLASS OF LIPIDS FOR DELIVERING ACTIVE INGREDIENTS INTO CELLS | OZ BIOSCIENCES (FR) | 2024-12-26 | — | — | WO | disclosed |
| EP-4480943-A1 | NEW CLASS OF LIPIDS FOR DELIVERING ACTIVE INGREDIENTS INTO CELLS | Oz Biosciences (FR) | 2024-12-25 | — | — | EP | disclosed |
| CN-112839933-B | Pesticidally active benzene-amide and azine-amide compounds | 先正达参股股份有限公司 | 2024-12-13 | — | — | CN | disclosed |
| WO-2024189588-A1 | BEVERAGES CONTAINING NATURAL PRODUCTS | KENNEDY J PHILLIP (US) | 2024-09-19 | — | — | WO | disclosed |
| US-20240307472-A1 | BEVERAGES CONTAINING NATURAL PRODUCTS | PK Beverages LLC (US) | 2024-09-19 | — | — | US | disclosed |
| US-20170107208-A1 | SYNTHETIC PROCESS | THE UNIVERSITY OF LIVERPOOL (GB) | 2017-04-20 | — | — | US | disclosed |
| EP-3122725-A1 | SYNTHETIC PROCESS | The University of Liverpool (GB) | 2017-02-01 | — | — | EP | disclosed |
| WO-2015145143-A1 | SYNTHETIC PROCESS | THE UNIVERSITY OF LIVERPOOL (GB) | 2015-10-01 | — | — | WO | disclosed |
| CN-104840505-A | Application of aizoon stonecrop herb to preparation of composition for inhibiting itching caused by mosquito bite | LUOYANG GUCHENG BIOTECHNOLOGY CO LTD | 2015-08-19 | — | — | CN | disclosed |
| US-20100098788-A1 | Extracts of Curcuma and Methods of Use Thereof | HERBALSCIENCE GROUP, LLC | 2010-04-22 | — | — | US | disclosed |
| EP-1360327-A4 | METHOD FOR IDENTIFYING GENES REGULATING DESIRED CELL PHENOTYPES | GALILEO PHARMACEUTICALS INC (US) | 2005-07-13 | — | — | EP | disclosed |
| EP-1360327-A1 | METHOD FOR IDENTIFYING GENES REGULATING DESIRED CELL PHENOTYPES | PHYTERA, INC. (US) | 2003-11-12 | — | — | EP | disclosed |
| WO-2002059374-A1 | METHOD FOR IDENTIFYING GENES REGULATING DESIRED CELL PHENOTYPES | PHYTERA, INC. (US) | 2002-08-01 | — | — | WO | disclosed |
| US-6362009-B1 | CAPTURING A SUBSTRATE ON SOLID SUPPORT AND ACTIVATINGSUBSTRATE TO REACT WITH REAGENT WITH WHICH UNACTIVATED SUBSTRATE DOES NOT REACT; REACTING ACTIVATED SUBSTRATE ON SOLID PHASE WITH REAGENT TO GIVE AN ADDITION PRODUCT | MERCK & CO., INC. | 2002-03-26 | — | — | US | disclosed |
| US-4556515-A | CONDENSATION OF AN OXIME SULFATE AND SILYL ENOL ETHER | TOYO STAUFFER CHEMICAL CO., LTD. (JP) | 1985-12-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12539298-B2 | Lobinaline N-oxides as positive allosteric modulators of the dopamine transporter with potential value in the treatment of substance abuse disorders | SLC18A3, SLC18A2, SLC6A3 | CYP2D6 1327/4885CYP1A2 654/4885HIF1A 4654/4885 |
| US-20240307472-A1 | BEVERAGES CONTAINING NATURAL PRODUCTS | FABP3, SIRT3, SIRT5 | CYP2D6 2642/4885CYP1A2 3155/4885HIF1A 949/4885 |
| US-20170107208-A1 | SYNTHETIC PROCESS | PIR, SRM, SMS | CYP2D6 111/4885CYP1A2 176/4885HIF1A 3125/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.